CardiacWire
AUGUST 18, 2024
The White House finally unveiled its negotiated Medicare drug prices , bringing 38%-76% reductions to the first 10 drugs, while drawing mixed industry reactions. Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time.
DAIC
JANUARY 29, 2024
The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.
DAIC
DECEMBER 5, 2024
This funding will allow us to expand our commercial reach, which is especially germane following our recent achievements in attaining Medicare coverage and a CPT Category I code for advanced plaque analysis. We’re proud to be a part of Cleerly’s journey. This is what good software can do in the world!"
HCPLive
JULY 29, 2024
The approval of Guardant Health’s Shield test makes it the first blood test to be approved as a primary screening option for CRC and the first to meet Medicare coverage requirements.
HCPLive
MARCH 26, 2024
A hypothetical triennial blood-based screening test meeting Centers for Medicare and Medicaid Services coverage criteria was cost-effective versus no screening but not compared to FIT, sDNA-FIT, or colonoscopy.
DAIC
JANUARY 24, 2025
Medicare beneficiaries who underwent CABG from 2001 to 2019. They noted that because their analysis was focused on the Medicare population, the cohort was limited to older patients. With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the U.S.,
Stroke Journal
DECEMBER 8, 2023
BACKGROUND:Stroke is the fifth leading cause of death in the United States, one of the leading contributors to Medicare cost, including through Medicare hospice benefits, and the rate of stroke mortality has been increasing since 2013. from 78 812 to 160 884. from 78 812 to 160 884. P<0.001). P<0.001).
Expert insights. Personalized for you.
59 
Let's personalize your content